Tag: Prescription Drugs
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis
Among patients with atopic dermatitis and self-reported race other than White, 68.3 percent achieved EASI 75 at week 16
AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe Alopecia
Patients achieving SALT score ≤20 increased from 44.5 to 75.8 percent at week 52 to week 76
ADHD Meds Initiation Linked to Lower Rate of All-Cause Mortality
Significantly lower rates seen for all-cause mortality and unnatural-cause mortality, but not natural-cause mortality
AAN: Monoclonal Antibodies for MS During Breastfeeding Not Harmful
No association seen for mAb during breastfeeding with infant hospitalization, systemic antibiotic use, developmental delay
Long-Acting Injectable ART Superior to Standard Care for Poorly Adherent People With HIV
Key secondary end points of virologic failure and treatment-related failure met predefined stopping criterion
Prevalence of Increased Residual Gastric Content Increased With GLP-1 RAs
GLP-1 RA use associated with higher prevalence of residual gastric content in participants undergoing elective procedure under anesthesia
Prevalence of Self-Reported Hypertension 30 Percent in 2017 to 2021
During the same time period, the prevalence of antihypertensive medication use increased from 59.8 to 62.9 percent
ALS Drug Relyvrio May Be Pulled From Market
Manufacturer may pull medication from the market following lackluster results from a large trial
Nirsevimab Effective for Preventing RSV-Linked Hospitalization
Single dose of nirsevimab 90 percent effective against RSV-associated hospitalization among infants
FDA Approves Wegovy to Lower Risk for CVD Events in Patients With Obesity
Agency's action could widen access to the drug if more insurance companies decide to cover it